Phase I trial of vandetanib and oral etoposide (VP-16) for recurrent malignant gliomas (MG).

被引：1
|
作者：
Brickhouse, A. [1 ]
Vredenburgh, J. J. [1 ]
Gururangan, S. [1 ]
Reardon, D. A. [1 ]
Desjardins, A. [1 ]
Peters, K. [1 ]
Herndon, J. E. [1 ]
Norfleet, J. [1 ]
Marcello, J. [1 ]
Friedman, H. S. [1 ]
机构：
[1] Duke Univ, Med Ctr, Durham, NC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.2038
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2038
引用
收藏
页数：1
相关论文
共 50 条
  • [21] TREATMENT OF REFRACTORY OR RECURRENT MALIGNANT-LYMPHOMAS WITH A COMBINATION OF ETOPOSIDE (VP-16), IFOSFAMIDE, METHOTREXATE, AND BLEOMYCIN (VIMB)
    NOWROUSIAN, MR
    SCHOETENSACK, B
    ANDERS, C
    NIEDERLE, N
    PFEIFFER, R
    SEEBER, S
    SCHMIDT, CG
    BLUT, 1987, 55 (04): : 333 - 333
  • [22] Temozolomide and oral VP-16 for children and young adults with recurrent or secondary malignant brain tumors
    Korones, DN
    Smith, AA
    Bouffer, F
    Foreman, N
    NEURO-ONCOLOGY, 2004, 6 (04) : 460 - 461
  • [23] Long-term oral VP-16 for recurrent medulloblastoma
    Chamberlain, MC
    ANNALS OF NEUROLOGY, 1997, 42 (03) : P135 - P135
  • [24] Phase 1 Dose Escalation Trial of Vandetanib with Fractionated Radiosurgery in Patients with Recurrent Malignant Gliomas
    Fields, E. C.
    Damek, D. M.
    Liu, A. K.
    Gaspar, L. E.
    Kavanagh, B. D.
    Waziri, A. E.
    Lillehei, K.
    Chen, C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S171 - S172
  • [25] A phase I trial of Avonex for patients with recurrent malignant gliomas
    Wen, PY
    Robertson, M
    ONeil, A
    Loeffler, JS
    Black, PM
    Fine, HA
    NEUROLOGY, 1997, 48 (03) : 1003 - 1003
  • [26] PHASE-II TRIAL OF VP-16 IN APUDOMAS
    FIORE, JJ
    KELSEN, DP
    CHENG, E
    DUKEMAN, M
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 174 - 174
  • [27] Results of phase I-II trial of concomitant hyperfractionated radiation and oral etoposide (VP-16) in patients with unresectable squamous cell carcinoma of the head and neck
    Khafif, A
    Canfield, VA
    Syzek, EJ
    Medina, JE
    AMERICAN JOURNAL OF OTOLARYNGOLOGY, 2003, 24 (01) : 1 - 5
  • [28] Phase I study of karenitecin in the treatment of recurrent malignant gliomas (MG)
    Lesser, GJ
    Grossman, SA
    Carson, K
    Phupanich, S
    Batchelor, T
    Peereboom, D
    Nabors, LB
    Supko, J
    Hausheer, F
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 120S - 120S
  • [29] ETOPOSIDE (VP-16), IFOSFAMIDE MESNA, AND CISPLATIN CHEMOTHERAPY FOR ADVANCED AND RECURRENT CARCINOMA OF THE CERVIX
    KREDENTSER, DC
    GYNECOLOGIC ONCOLOGY, 1991, 43 (02) : 145 - 148
  • [30] A phase I trial of intratumoral (IT) administration of reovirus in patients with histologically confirmed recurrent malignant gliomas (MG)
    Forsyth, P. A.
    Roldan, G.
    George, D.
    Wallace, C.
    Morris, D. G.
    Cairncross, G.
    Matthews, M. Vallee
    Markert, J.
    Gillespie, Y.
    Coffey, M.
    Thompson, B.
    Hamilton, M.
    NEURO-ONCOLOGY, 2006, 8 (04) : 442 - 442
12345